Page last updated: 2024-09-05

sch 58261 and mre 3008-f20

sch 58261 has been researched along with mre 3008-f20 in 3 studies

Compound Research Comparison

Studies (sch 58261)	Trials (sch 58261)	Recent Studies (post-2010) (sch 58261)	Studies (mre 3008-f20)	Trials (mre 3008-f20)	Recent Studies (post-2010) (mre 3008-f20)
46	0	14	27	0	8

Protein Interaction Comparison

Protein	Taxonomy	sch 58261 (IC50)	mre 3008-f20 (IC50)
Adenosine receptor A3	Homo sapiens (human)		0.0048

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, ZG; Jacobson, KA	1
Bacilieri, M; Bolcato, C; Cacciari, B; Cardin, R; Federico, S; Kachler, S; Klotz, KN; Michielan, L; Moro, S; Pastorin, G; Spalluto, G; Sperduti, A	1
Aghazadeh Tabrizi, M; Baraldi, PG; Baraldi, S; Borea, PA; Moorman, AR; Preti, D; Romagnoli, R; Saponaro, G; Varani, K	1

Reviews

1 review(s) available for sch 58261 and mre 3008-f20

Article	Year
Adenosine receptors as therapeutic targets. Nature reviews. Drug discovery, 2006, Volume: 5, Issue:3 Topics: Animals; Disease; Drug Therapy; Humans; Ligands; Molecular Structure; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Structure-Activity Relationship	2006

Other Studies

2 other study(ies) available for sch 58261 and mre 3008-f20

Article	Year
Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites. Bioorganic & medicinal chemistry, 2009, Jul-15, Volume: 17, Issue:14 Topics: Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Artificial Intelligence; Binding Sites; Drug Discovery; Humans; Models, Chemical; Protein Binding; Pyrazoles; Pyrimidines; Receptor, Adenosine A2A; Receptor, Adenosine A3; Static Electricity; Structure-Activity Relationship; Triazoles	2009
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists. Bioorganic & medicinal chemistry, 2012, Jan-15, Volume: 20, Issue:2 Topics: Humans; Protein Binding; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyrimidines; Receptor, Adenosine A2A; Receptor, Adenosine A3; Structure-Activity Relationship; Triazoles	2012

Article

Year

Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites.

Bioorganic & medicinal chemistry, 2009, Jul-15, Volume: 17, Issue:14

Topics: Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Antagonists; Artificial Intelligence; Binding Sites; Drug Discovery; Humans; Models, Chemical; Protein Binding; Pyrazoles; Pyrimidines; Receptor, Adenosine A2A; Receptor, Adenosine A3; Static Electricity; Structure-Activity Relationship; Triazoles

2009

Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.

Bioorganic & medicinal chemistry, 2012, Jan-15, Volume: 20, Issue:2

Topics: Humans; Protein Binding; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyrimidines; Receptor, Adenosine A2A; Receptor, Adenosine A3; Structure-Activity Relationship; Triazoles

2012